Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

21 May 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

nelfinavir Articles

Small US Drug Firms Post Quarterly Results

19 August 1996

Phase II Nelfinavir Data Presented

29 July 1996

Update On Viracept Progress

27 May 1996

Clinical Progress For US Biopharma Firms In 1st Qtr

6 May 1996

Nelfinavir In Japan

19 February 1996

Triple Therapies For HIV Provide Encouraging Data

5 February 1996

Transition For AHP in 1995; Year-End Results

5 February 1996

Agouron Pushes Viracept Towards Pivotal Trials

15 January 1996

Many US Biotech Firms See Good 3rd Qtr Sales Growth

13 November 1995

Agouron Pharma: Viracept news

2 October 1995

Agouron's Viracept: Pilot Phase II Data

25 September 1995

Showing 101-111 of 111 articles

Go to beginningPrevious
  • 1
  • 2
NextGo to end
  • Hot Topics
  • Most Read
  • Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
  • Elan makes "transformational" acquisitions and a divestment
  • HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
  • Is failure to adopt business process management putting the pharma industry at risk?
  • Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
  • Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
  • Elan makes "transformational" acquisitions and a divestment
  • HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
  • Is failure to adopt business process management putting the pharma industry at risk?
  • Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS